
Multiple System Atrophy: Multimodal Biomarkers and Clinical Phenotypes
This review article explores Multiple system atrophy (MSA), a rare and aggressive neurodegenerative disease defined by the buildup of α-synuclein protein. The authors examine the shift toward a two-co...
21 Jun 22min

IV Fosphenytoin for Acute Trigeminal Neuralgia Exacerbations
This source describes a phase 3 clinical trial investigating the effectiveness of intravenous fosphenytoin for treating sudden, intense flare-ups of trigeminal neuralgia. While standard oral medicatio...
21 Jun 17min

Drugs for Migraine Prophylaxis
This medical review examines current pharmacological strategies for migraine prophylaxis, distinguishing between episodic and chronic forms of the condition. The authors evaluate traditional oral ther...
14 Jun 10min

Intrathecal Mesenchymal Stem Cells in Progressive MS: The SMART-MS Trial
This randomized, double-blind study investigated the potential for autologous mesenchymal stem cells (MSCs) to repair neurological damage in patients with progressive multiple sclerosis. Using an intr...
7 Jun 19min

Neurologic Adverse Events from Immune Checkpoint Inhibitors
Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment, but they can trigger a wide range of neurological immune-related adverse events (irAE) by disrupting immune tolerance. These co...
31 Mai 20min

Anti-KLHL11 Encephalitis
This study examines the clinical characteristics and long-term outcomes of anti-KLHL11 encephalitis, a rare paraneoplastic neurologic syndrome primarily affecting middle-aged men. Researchers identifi...
31 Mai 21min

Sleep Neurology: Pearls and Pitfalls for the Practising Neurologist
This clinical review highlights frequent diagnostic and therapeutic errors encountered by neurologists when managing sleep disorders. The authors emphasize that chronic insomnia should primarily be tr...
25 Mai 19min

Tavapadon as Adjunctive Therapy for Parkinson Disease - TEMPO-3 Trial
The provided sources detail phase 3 clinical trial results for tavapadon, a novel, once-daily dopamine D1/D5 receptor agonist designed to treat Parkinson disease. In the TEMPO-1 study, fixed doses of ...
24 Mai 16min



















